Fluorinov Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $31.7M

Fluorinov Pharma General Information

Description

Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's services include developing small molecule product portfolio for Multiple Myeloma, Waldenström's Macroglobulinemia, Leukemia, Glioblastoma, Lung and Pancreatic Cancers and Central Nervous System disorders, enabling patients to avail therapeutics to treat and avoid cancer diseases.

Contact Information

Website
www.fluorinovpharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 101 College Street, MaRS Centre, South Tower
  • Suite 300, L-349
  • Toronto, Ontario M5G 1L7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Trillium Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 101 College Street, MaRS Centre, South Tower
  • Suite 300, L-349
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluorinov Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 27-Jan-2016 $31.7M 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 07-Jan-2015 00.000 Completed Generating Revenue
2. Early Stage VC 07-Jun-2012 $1.47M $1.47M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Generating Revenue
To view Fluorinov Pharma’s complete valuation and funding history, request access »

Fluorinov Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The co
Drug Discovery
Toronto, Canada
00.000
000.00 0000-00-00
000000&0 00.000

000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000000
South San Francisco, CA
00000 As of 0000
00.000
00000 0000-00-00
00000000000 00.000

000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000 000000000
Stockholm, Sweden
00 As of 0000
000.00
000.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fluorinov Pharma Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden 00 000.00 0000000000 0 000.00
Sanofi Corporation Paris, France 00000 00.00 000000000 00.00
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 - 000.00
Cardurion Venture Capital-Backed Burlington, MA 00 00000 00000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Fluorinov Pharma Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Fluorinov Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190016689-A1 Novel fluorinated quinazoline derivatives as egfr inhibitors Inactive 06-Jan-2016 0000000000
CA-2881986-A1 Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors Inactive 21-Aug-2012 0000000000

Fluorinov Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
FACIT Venture Capital Minority 000 0000 000000 0
Ontario Institute for Cancer Research Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Fluorinov Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Fluorinov Pharma FAQs

  • When was Fluorinov Pharma founded?

    Fluorinov Pharma was founded in 2008.

  • Who is the founder of Fluorinov Pharma?

    Malik Slassi is the founder of Fluorinov Pharma.

  • Where is Fluorinov Pharma headquartered?

    Fluorinov Pharma is headquartered in Toronto, Canada.

  • What industry is Fluorinov Pharma in?

    Fluorinov Pharma’s primary industry is Drug Discovery.

  • Is Fluorinov Pharma a private or public company?

    Fluorinov Pharma is a Private company.

  • What is the current valuation of Fluorinov Pharma?

    The current valuation of Fluorinov Pharma is 000.00.

  • What is Fluorinov Pharma’s current revenue?

    The current revenue for Fluorinov Pharma is 000000.

  • How much funding has Fluorinov Pharma raised over time?

    Fluorinov Pharma has raised $1.47M.

  • Who are Fluorinov Pharma’s investors?

    FACIT and Ontario Institute for Cancer Research have invested in Fluorinov Pharma.

  • Who are Fluorinov Pharma’s competitors?

    Genentech, Gesynta Pharma, Sanofi, Amgen, and Cardurion are some of the 14 competitors of Fluorinov Pharma.

  • When was Fluorinov Pharma acquired?

    Fluorinov Pharma was acquired on 27-Jan-2016.

  • Who acquired Fluorinov Pharma?

    Fluorinov Pharma was acquired by Trillium Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »